GERN
GERON CORP
NASDAQ · Healthcare · Biotechnology · US
$1.04
+11.29%Forward multiples
Based on analyst estimates
- P/E forward
- 22.53x
- P/E 2026E
- —
- P/E 2027E
- 13.45x
- P/E 2028E
- 3.98x
- P/S forward
- 2.10x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.04x
- Price / sales
- 3.25x
- Price / cash flow
- -5.81x
Enterprise value
- Enterprise value
- $486.3M
- EV / sales
- 2.38x
- EV / EBITDA
- -11.75x
- EV / EBIT
- -13.00x
- Market cap
- $665.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026